US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application

Perrigo's HRA Pharma submits to FDA on 11 July an NDA by for OTC 0.075-mg norgestrel, branded Opill, The same formulation previously was available Rx 30 years. 

• Source: Shutterstock

US consumers could know in 10 months whether a daily oral contraceptive for the first time will be approved for OTC sales.

The question is posed to the Food and Drug Administration in a new drug application submitted on 11 July by...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Rx-to-OTC Switch

More from Health